Use of the Passy Muir Swallowing Self Trainer
NCT02848664 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11
Last updated 2019-03-11
Summary
The purpose of this study is to develop appropriate training methods and gather participant feedback on their use of the Passy Muir Swallowing Self-Training Device (PMSST). The PMSST is a small device that provides external vibratory stimulation to the larynx during swallowing and swallowing training. A secondary purpose of the study is to determine how 3 months of use of the PMSST affects swallowing physiology, brain activation, oral intake and quality of life. This was an uncontrolled pilot study aimed at gaining patient feedback on use of the vibratory device.
Conditions
- Stroke
- Brain Injury
- Head and Neck Cancer
Interventions
- DEVICE
-
Dysphagia retraining with device
Patients used the device for 60 trials of retraining swallowing at home each day and also had the device turned on throughout the day in automatic mode to intermittently trigger every few minutes to trigger a swallow for saliva control
Sponsors & Collaborators
-
Passy Muir Inc.
collaborator INDUSTRY -
James Madison University
lead OTHER
Principal Investigators
-
Erin Kamarunas, PhD · James Madison University
Eligibility
- Min Age
- 13 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-08-31
- Primary Completion
- 2015-08-31
- Completion
- 2015-08-31
Countries
- United States
Study Locations
More Related Trials
-
Phagenyx® Registry Study
NCT06866418 ·Status: RECRUITING
-
Accurate Screening Tools for Dysphagia in Amyotrophic Lateral Sclerosis (ALS)
NCT02710162 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Transmembrane Electromyography (TM-EMG) for the Assessment of Neuromuscular Function in the Oropharynx
NCT03986671 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Home Based Assessments on Participants With DMD
NCT05657938 ·Status: COMPLETED
-
Stem Cell Therapy in Duchenne Muscular Dystrophy
NCT02241434 ·Status: WITHDRAWN ·Phase: PHASE1
-
New Imaging Biomarkers for Muscular Diseases - Multispectral Optoacoustic Imaging in Spinal Muscular Atrophy
NCT04115475 ·Status: COMPLETED ·Phase: NA
-
Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
NCT01730716 ·Status: UNKNOWN ·Phase: PHASE2
-
Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy
NCT01671865 ·Status: ACTIVE_NOT_RECRUITING
-
Remote Speech and Swallowing Assessment in ALS
NCT04889898 ·Status: ACTIVE_NOT_RECRUITING
-
The Safety, Efficacy and Tolerability of Remote Ischemic Preconditioning as a Therapy to DMD
NCT02614820 ·Status: UNKNOWN ·Phase: NA
-
Effect of Functional Exercise in Patients With Spinal Bulbar Muscular Atrophy
NCT01369901 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families
NCT03680365 ·Status: COMPLETED
-
Early Treatment of Amyotrophic Lateral Sclerosis (ALS) With Nutrition and Non-Invasive Positive Pressure Ventilation
NCT00116558 ·Status: COMPLETED ·Phase: NA
-
Progressive Strength Training in Spinal Muscular Atrophy
NCT01233817 ·Status: COMPLETED ·Phase: NA
-
Cell Therapy in Limb Girdle Muscular Dystrophy
NCT02245711 ·Status: WITHDRAWN ·Phase: PHASE1
-
Diagnostic Journey, Patient Experience, and Disparities in the Treatment of Spinal Muscular Atrophy (SMA) in the MedStar Health System
NCT07223489 ·Status: RECRUITING
-
Studying Skeletal Muscle, Heart, and Diaphragm Imaging in Boys With Duchenne Muscular Dystrophy
NCT01451281 ·Status: COMPLETED
-
NeuRx Diaphram Pacing System (DPS) Use in Amyotrophic Lateral Sclerosis (ALS)
NCT03034317 ·Status: WITHDRAWN ·Phase: NA
-
Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis
NCT01082653 ·Status: SUSPENDED ·Phase: PHASE1
-
Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis
NCT00023075 ·Status: COMPLETED
-
Intramuscular Infusion of Autologous Bone Marrow Stem Cells in Patients With Amyotrophic Lateral Sclerosis
NCT02286011 ·Status: UNKNOWN ·Phase: PHASE1
-
Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders
NCT02118805 ·Status: COMPLETED
-
Therapeutic Treatment of Amyotrophic Lateral Sclerosis
NCT02881476 ·Status: UNKNOWN ·Phase: PHASE1
-
Exploratory Study of Biotelemetry in Amyotrophic Lateral Sclerosis
NCT02447952 ·Status: COMPLETED ·Phase: NA
-
Whole Body Vibration Therapy in Boys With Duchenne Muscular Dystrophy
NCT01954940 ·Status: COMPLETED ·Phase: NA